Defence Therapeutics Inc. (FRA:DTC)
0.502
-0.040 (-7.38%)
At close: Dec 4, 2025
Defence Therapeutics Market Cap
Defence Therapeutics has a market cap or net worth of €31.28 million as of December 5, 2025. Its market cap has increased by 85.62% in one year.
Market Cap
31.28M
Enterprise Value
31.69M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.50
Market Cap Chart
Since May 7, 2021, Defence Therapeutics's market cap has decreased from 60.36M to 31.28M, a decrease of -48.17%. That is a compound annual growth rate of -13.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 31.73M | 50.13% |
| Dec 31, 2024 | 21.13M | -70.23% |
| Dec 29, 2023 | 70.98M | 4.33% |
| Dec 30, 2022 | 68.04M | -49.69% |
| Dec 31, 2021 | 135.24M | 124.04% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 98.87B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.10B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |